Computational nanobody design using graph neural networks and Metropolis Monte Carlo sampling.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42015415.
- Also identified by DOI 10.1093/bib/bbag180 and PMC identifier 13099421.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Nanobodies are promising protein therapeutics due to their high-stability, low immunogenicity, and ease of production. However, experimental screening of high-affinity nanobodies and their post optimization remain costly and time-consuming due to the vast variant space. Here, we developed a computational approach that integrates graph neural networks (GNNs) with Monte Carlo Metropolis algorithm for nanobody design. We constructed a GNN model, AiPPA, to predict the protein-protein binding free energy (BFE) without requiring the complex structure, achieving a Pearson correlation of 0.62 on benchmark. We then combined AiPPA with Metropolis importance sampling to design low-BFE nanobodies from a non-affinity template. We applied this method to the antigen TL1A and generated two affinity nanobodies. This work establishes a physics-informed deep learning method for computational nanobody design, providing a novel development strategy for protein therapeutics.
Medical subject headings
- Monte Carlo Method
- Single-Domain Antibodies
- Neural Networks, Computer
- Computational Biology